SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001144204-16-089202
Filing Date
2016-03-21
Accepted
2016-03-21 16:35:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G v434907_sc13g.htm SC 13G 45899
  Complete submission text file 0001144204-16-089202.txt   47590
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Subject) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-46247 | Film No.: 161519067
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address NO 16 STREET, XIASHA ECONOMIC TECH DEVELOPMENT HANGZHOU ZHEJIANG F4 31008
Business Address NO 16 STREET, XIASHA ECONOMIC TECH DEVELOPMENT HANGZHOU ZHEJIANG F4 31008 8657186913770
Zhejiang Kanglaite Group Co., LTD (Filed by) CIK: 0001669491 (see all company filings)

IRS No.: 000000000 | State of Incorp.: F4 | Fiscal Year End: 1231
Type: SC 13G